HDL Dysfunction Is the Answer in the Sphinx's Riddle?

Journal of the American College of Cardiology

Volumn 66, Issue 13, 2015, Pages 1486-1488

  Badimon, Juan J ^a   Santos Gallego, Carlos G ^a  

^a MOUNT SINAI SCHOOL OF MEDICINE   (United States)

Author keywords

apo A I; apo M; coronary artery disease; high density lipoproteins; sphingosine 1 phosphate

Indexed keywords

APOLIPOPROTEIN M; FINGOLIMOD; HIGH DENSITY LIPOPROTEIN; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; PROTEOME; SPHINGOSINE 1 PHOSPHATE; SPHINGOSINE 1 PHOSPHATE RECEPTOR; LYSOPHOSPHOLIPID; SPHINGOSINE;

ANTIINFLAMMATORY ACTIVITY; CORONARY ARTERY ATHEROSCLEROSIS; CORONARY ARTERY DISEASE; CORRELATIONAL STUDY; DISORDERS OF LIPOPROTEIN METABOLISM; DOWN REGULATION; EDITORIAL; ENDOTHELIAL DYSFUNCTION; HIGH DENSITY LIPOPROTEIN DYSFUNCTION; HISTORY OF MEDICINE; HUMAN; NONHUMAN; NOTE; PHOSPHOLIPID SYNTHESIS; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN FUNCTION; PROTEIN LIPID INTERACTION; PROTEIN PROTEIN INTERACTION; UPREGULATION; VASCULAR ENDOTHELIUM; VASODILATATION; ANALOGS AND DERIVATIVES; ANIMAL; BLOOD;

ANIMALS; CORONARY ARTERY DISEASE; HUMANS; LIPOPROTEINS, HDL; LYSOPHOSPHOLIPIDS; SPHINGOSINE;

EID: 84941677540     PISSN: 07351097     EISSN: 15583597     Source Type: Journal    
DOI: 10.1016/j.jacc.2015.08.008     Document Type: Editorial

References (15)

1. J.L.W. Thudichum A Treatise on the Chemical Constitution of Brain 1884 Bailliere, Tindall and Cox London
2. C.G. Santos-Gallego, J.J. Badimon, and R.S. Rosenson Beginning to understand high-density lipoproteins Endocrinol Metab Clin North Am 43 2014 913 947
3. K. Sattler, M. Gräler, P. Keul, and et al. Defects of high-density lipoproteins in coronary artery disease caused by low sphingosine-1-phosphate content: correction by sphingosine-1-phosphate - loading J Am Coll Cardiol 66 2015 1470 1485
4. C.G. Santos-Gallego, B. Picatoste, and J.J. Badimon Pathophysiology of acute coronary syndrome Curr Atheroscler Rep 16 2014 401
5. W.E. Boden, J.L. Probstfield, T. Anderson, and et al. Niacin in patients with low HDL cholesterol levels receiving intensive statin therapy N Engl J Med 365 2011 2255 2267
6. A. Rohatgi, A. Khera, J.D. Berry, and et al. HDL cholesterol efflux capacity and incident cardiovascular events N Engl J Med 371 2014 2383 2393
7. Y. Huang, J.A. Didonato, B.S. Levison, and et al. An abundant dysfunctional apolipoprotein A1 in human atheroma Nat Med 20 2014 193 203
8. C. Christoffersen, H. Obinata, S.B. Kumaraswamy, and et al. Endothelium-protective sphingosine-1-phosphate provided by HDL-associated apolipoprotein M Proc Natl Acad Sci U S A 108 2011 9613 9618
9. F. Poti, U. Ceglarek, R. Burkhardt, M. Simoni, and J.R. Nofer SKI-II-a sphingosine kinase 1 inhibitor-exacerbates atherosclerosis in low-density lipoprotein receptor-deficient (LDL-R-/-) mice on high cholesterol diet Atherosclerosis 240 2015 212 215
10. M. Bot, P.P. Van Veldhoven, S.C. de Jager, and et al. Hematopoietic sphingosine 1-phosphate lyase deficiency decreases atherosclerotic lesion development in LDL-receptor deficient mice PLoS One 8 2013 e63360
11. J.R. Nofer, M. Bot, M. Brodde, and et al. FTY720, a synthetic sphingosine 1 phosphate analogue, inhibits development of atherosclerosis in low-density lipoprotein receptor-deficient mice Circulation 115 2007 501 508
12. P. Keul, M. Tolle, S. Lucke, and et al. The sphingosine-1-phosphate analogue FTY720 reduces atherosclerosis in apolipoprotein E-deficient mice Arterioscler Thromb Vasc Biol 27 2007 607 613
13. K.J. Sattler, S. Elbasan, P. Keul, and et al. Sphingosine 1-phosphate levels in plasma and HDL are altered in coronary artery disease Basic Res Cardiol 105 2010 821 832
14. J.R. Nofer, M. van der Giet, M. Tolle, and et al. HDL induces NO-dependent vasorelaxation via the lysophospholipid receptor S1P3 J Clin Invest 113 2004 569 581
15. T. Kimura, K. Sato, E. Malchinkhuu, and et al. High-density lipoprotein stimulates endothelial cell migration and survival through sphingosine 1-phosphate and its receptors Arterioscler Thromb Vasc Biol 23 2003 1283 1288